{
    "organizations": [],
    "uuid": "3dd9037e3e7b4efbf70ae500da20c997a60d5ac5",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-abbott-initiates-trial-to-evaluate/brief-abbott-initiates-trial-to-evaluate-improved-survival-and-outcomes-with-the-cardiomems-monitor-idUSFWN1RB0L5",
    "ord_in_thread": 0,
    "title": "Abbott Initiates Trial To Evaluate Improved Survival And Outcomes With The Cardiomems Monitor",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 29 (Reuters) - Abbott Laboratories:\n* ABBOTT INITIATES TRIAL TO EVALUATE IMPROVED SURVIVAL AND OUTCOMES WITH THE CARDIOMEMS MONITOR\n* ABBOTT LABORATORIES - NEW STUDY WILL EVALUATE WHETHER TREATMENT WITH CARDIOMEMS MONITOR IMPROVES SURVIVAL AND OUTCOMES FOR MORE PEOPLE Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-29T21:08:00.000+03:00",
    "crawled": "2018-03-30T13:22:45.017+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "abbott",
        "laboratory",
        "abbott",
        "initiate",
        "trial",
        "evaluate",
        "improved",
        "survival",
        "outcome",
        "cardiomems",
        "monitor",
        "abbott",
        "laboratory",
        "new",
        "study",
        "evaluate",
        "whether",
        "treatment",
        "cardiomems",
        "monitor",
        "improves",
        "survival",
        "outcome",
        "people",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}